We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,704
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCG
7101
RENN Fund
RCG
$21.2M
$10K ﹤0.01%
6,464
+1,424
+28% +$2.17K
REW icon
7102
Proshares UltraShort Technology
REW
$3.47M
$10K ﹤0.01%
+6
New +$10.2K
RGLS
7103
DELISTED
Regulus Therapeutics
RGLS
$10K ﹤0.01%
+125
New +$10.3K
SHYL icon
7104
Xtrackers Short Duration High Yield Bond ETF
SHYL
$268M
$10K ﹤0.01%
+200
New +$9.9K
STG
7105
Sunlands Technology
STG
$44.1M
$10K ﹤0.01%
+87
New +$9.91K
VYGR icon
7106
Voyager Therapeutics
VYGR
$183M
$10K ﹤0.01%
500
-35,875
-99% -$709K
WORX
7107
DELISTED
SCWORX CORP NEW
WORX
$10K ﹤0.01%
7
NTRP icon
7108
NextTrip
NTRP
$24.2M
$10K ﹤0.01%
53
+34
+179% +$8.63K
GRDX
7109
GridAI Technologies Corp
GRDX
$20.4M
0
TGEN
7110
Tecogen Inc
TGEN
$99.3M
$10K ﹤0.01%
2,765
+701
+34% +$2.42K
AE
7111
DELISTED
Adams Resources & Energy Inc
AE
$10K ﹤0.01%
234
-605
-72% -$27.5K
YTEN
7112
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$10K ﹤0.01%
7
+4
+133% +$6.34K
CYTO
7113
DELISTED
Altamira Therapeutics Ltd
CYTO
$10K ﹤0.01%
+2
New +$21.1K
RENO
7114
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$10K ﹤0.01%
+2,480
New +$9.4K
CPTAG
7115
DELISTED
Capitala Finance Corp. 5.75% Convertible Notes Due 2022
CPTAG
$10K ﹤0.01%
400
BFRA
7116
DELISTED
Biofrontera AG American Depositary Shares
BFRA
$10K ﹤0.01%
+856
New +$11.6K
IEC
7117
DELISTED
IEC Electronics Corp.
IEC
$10K ﹤0.01%
1,793
+1,437
+404% +$7.44K
YGYI
7118
DELISTED
Youngevity International, Inc Common Stock
YGYI
$10K ﹤0.01%
2,488
-739
-23% -$2.75K
HUSN
7119
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$10K ﹤0.01%
+280
New +$14.8K
PSV
7120
DELISTED
Hermitage Offshore Services Ltd.
PSV
$10K ﹤0.01%
879
-18
-2% -$203
CYRXW
7121
DELISTED
CryoPort, Inc. Warrants
CYRXW
$10K ﹤0.01%
824
-300
-27% -$2.21K
FNJN
7122
DELISTED
Finjan Holdings, Inc.
FNJN
$10K ﹤0.01%
+2,880
New +$8.62K
LBY
7123
DELISTED
Libbey, Inc.
LBY
$10K ﹤0.01%
1,188
-1,056
-47% -$6.99K
OSIZ
7124
DELISTED
Invesco Russell 1000 Size Factor ETF
OSIZ
$10K ﹤0.01%
+400
New +$10.3K
FWP
7125
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$10K ﹤0.01%
502
+86
+21% +$1.49K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,704 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.